ECORNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
electroCore, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.22 (-2.80%)
Close on Oct 19, 2026
- Market cap
- $71.75K
- P/E (TTM)
- –
- Dividend yield
- –
electroCore, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioelectronic Innovations Segment [Member] | $32.03M | $25.18M | – | – | – | – | – | – | – | 100.0% | +27.2% |
| Medical Devices | – | $25.18M | $16.03M | – | – | – | – | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioelectronic Innovations Segment [Member] | -$13.15M | -$12.16M | – | – | – | – | – | – | – | +8.1% |
| Medical Devices | – | -$12.16M | -$19.27M | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | $23.33M | $14.21M | $6.97M | $3.94M | $2.37M | $1.61M | $619.77K | $243.19K | – | – |
| United Kingdom | – | $1.67M | $1.57M | $1.30M | $1.34M | $1.05M | $665.63K | $300.09K | $273.74K | – | – |
| Germany | – | – | – | – | $28.99K | $53.93K | $102.43K | $53.78K | $265.45K | – | – |
| Other | – | – | – | $183.00K | $167.00K | $16.01K | $16.41K | $19.31K | $29.07K | – | – |
| Japan | – | $65.00K | $102.00K | $139.00K | – | – | – | – | – | – | – |
| Other Countries [Member] | – | $119.00K | $148.00K | $183.00K | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of electroCore's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.